Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032

Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032



The global Antiparasitic Drugs market size is expected to reach USD 38.20 billion by 2032, according to a new study by Polaris Market Research. The report “Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Emerging markets in developing regions offer prime opportunities for the Antiparasitic Drugs Market. Improved healthcare infrastructure and heightened awareness drive demand for effective treatments against parasitic infections. With higher infection rates in these regions, pharmaceutical companies introduce accessible and affordable solutions, establishing strategic collaborations for market entry and expansion.

Targeted therapies present a pivotal opportunity in the antiparasitic drugs market, offering precise, personalized treatment for enhanced efficacy and minimized side effects. Leveraging advancements in molecular understanding, these therapies focus on specific parasites, providing innovative solutions with improved patient outcomes. Pharmaceutical companies investing in research and development of such targeted approaches position themselves for market leadership. This strategic move addresses the challenges of drug resistance while expanding treatment options, aligning with the evolving landscape of personalized medicine in antiparasitic drug development.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/antiparasitic-drugs-market/request-for-sample

Clinical trials play a pivotal role in shaping the antiparasitic drugs market. Beyond validating safety and efficacy, participation in rigorous trials positions pharmaceutical companies as innovators. Successful trials not only secure regulatory approvals but also establish credibility, gaining a competitive edge. This engagement fosters confidence among healthcare professionals, contributing to market growth. Furthermore, these trials broaden the spectrum of available treatment options, meeting evolving needs in the fight against parasitic infections and ensuring sustained market expansion.

Streamlined regulatory pathways, expedited approvals, and supportive frameworks create a conducive environment for pharmaceutical innovation. This backing allows companies to swiftly bring novel antiparasitic drugs to market, addressing critical healthcare needs. Collaborative efforts between regulatory bodies and industry players enable efficient processes, fostering timely market entry. The encouragement of innovative solutions, coupled with responsive regulatory frameworks, positions the antiparasitic drugs Market for sustained growth.

Antiparasitic Drugs Market Report Highlights

In 2023, the Anthelmintics segment accounted for significant market share owing to prevalence of helminthic infections, global health initiatives, and increased awareness.

In 2023, the injectable segment accounted for significant market share owing to rapid and direct response, and wide use in hospitals.

In 2023, the hospital pharmacy segment held significant revenue share owing to easy access for patients within healthcare institutions.

In 2023, North America region dominated the global market due to prevalence of parasitic infections, regulatory environment, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including Bayer AG, Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Ipca Laboratories Ltd, Merck & Co., Viatris, and Novartis among others.

Polaris Market Research has segmented the Antiparasitic Drugs market report based on type, route of administration, distribution channel, and region:

Antiparasitic Drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Antiprotozoals

Anthelmintics

Others

Antiparasitic Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

Topical

Oral

Injectable

Antiparasitic Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Retail Pharmacy

Hospital Pharmacy

Others

Antiparasitic Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
  • U.S.
  • Canada
Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
Latin America
  • Brazil
  • Mexico
  • Argentina
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Antiparasitic Drugs Market Insights
4.1. Antiparasitic Drugs Market – Distribution Channel Snapshot
4.2. Antiparasitic Drugs Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Global health initiatives are projected to spur the product demand
4.2.1.2. Prevalence of parasitic infections is expected to drive antiparasitic drugs market growth
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory challenges are likely to impede the market growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Antiparasitic Drugs Market Distribution Channel Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Antiparasitic Drugs Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
5.3. Antiprotozoals
5.3.1. Global Antiparasitic Drugs Market, by Antiprotozoals, by Region, 2019-2032 (USD Billion)
5.4. Anthelmintics
5.4.1. Global Antiparasitic Drugs Market, by Anthelmintics, by Region, 2019-2032 (USD Billion)
5.5. Others
5.5.1. Global Antiparasitic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Antiparasitic Drugs Market, by Route of Administration
6.1. Key Findings
6.2. Introduction
6.2.1. Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
6.3. Topical
6.3.1. Global Antiparasitic Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
6.4. Oral
6.4.1. Global Antiparasitic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
6.5. Injectable
6.5.1. Global Antiparasitic Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)
7. Global Antiparasitic Drugs Market, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.2.1. Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
7.3. Retail Pharmacy
7.3.1. Global Antiparasitic Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
7.4. Hospital Pharmacy
7.4.1. Global Antiparasitic Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
7.5. Others
7.5.1. Global Antiparasitic Drugs Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Antiparasitic Drugs Market, by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Antiparasitic Drugs Market – North America
8.3.1. North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.3.2. North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.3.3. North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.3.4. Antiparasitic Drugs Market – U.S.
8.3.4.1. U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.3.4.2. U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.3.4.3. U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.3.5. Antiparasitic Drugs Market – Canada
8.3.5.1. Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.3.5.2. Canada.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.3.5.3. Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4. Antiparasitic Drugs Market – Europe
8.4.1. Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.2. Europe.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.3. Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4.4. Antiparasitic Drugs Market – UK
8.4.4.1. UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.4.2. UK.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.4.3. UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4.5. Antiparasitic Drugs Market – France
8.4.5.1. France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.5.2. France.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.5.3. France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4.6. Antiparasitic Drugs Market – Germany
8.4.6.1. Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.6.2. Germany.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.6.3. Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4.7. Antiparasitic Drugs Market – Italy
8.4.7.1. Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.7.2. Italy.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.7.3. Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4.8. Antiparasitic Drugs Market – Spain
8.4.8.1. Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.8.2. Spain.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.8.3. Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4.9. Antiparasitic Drugs Market – Netherlands
8.4.9.1. Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.9.2. Netherlands.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.9.3. Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.4.10. Antiparasitic Drugs Market – Russia
8.4.10.1. Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.4.10.2. Russia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.4.10.3. Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.5. Antiparasitic Drugs Market – Asia Pacific
8.5.1. Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.5.2. Asia Pacific.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5.3. Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.5.4. Antiparasitic Drugs Market – China
8.5.4.1. China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.5.4.2. China.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5.4.3. China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.5.5. Antiparasitic Drugs Market – India
8.5.5.1. India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.5.5.2. India.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5.5.3. India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.5.6. Antiparasitic Drugs Market – Malaysia
8.5.6.1. Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.5.6.2. Malaysia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5.6.3. Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.5.7. Antiparasitic Drugs Market – Japan
8.5.7.1. Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.5.7.2. Japan.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5.7.3. Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.5.8. Antiparasitic Drugs Market – Indonesia
8.5.8.1. Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.5.8.2. Indonesia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5.8.3. Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.5.9. Antiparasitic Drugs Market – South Korea
8.5.9.1. South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.5.9.2. South Korea.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.5.9.3. South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.6. Antiparasitic Drugs Market – Middle East & Africa
8.6.1. Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.6.2. Middle East & Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.6.3. Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.6.4. Antiparasitic Drugs Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.6.4.2. Saudi Arabia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.6.4.3. Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.6.5. Antiparasitic Drugs Market – UAE
8.6.5.1. UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.6.5.2. UAE.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.6.5.3. UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.6.6. Antiparasitic Drugs Market – Israel
8.6.6.1. Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.6.6.2. Israel.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.6.6.3. Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.6.7. Antiparasitic Drugs Market – South Africa
8.6.7.1. South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.6.7.2. South Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.6.7.3. South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.7. Antiparasitic Drugs Market – Latin America
8.7.1. Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.7.2. Latin America.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.7.3. Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.7.4. Antiparasitic Drugs Market – Mexico
8.7.4.1. Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.7.4.2. Mexico.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.7.4.3. Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.7.5. Antiparasitic Drugs Market – Brazil
8.7.5.1. Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.7.5.2. Brazil.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.7.5.3. Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
8.7.6. Antiparasitic Drugs Market – Argentina
8.7.6.1. Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
8.7.6.2. Argentina.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
8.7.6.3. Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. AstraZeneca
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Bayer AG
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Cipla Limited
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Dr. Reddy's Laboratories
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. F. Hoffmann-La Roche Ltd
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. GlaxoSmithKline
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Ipca Laboratories Ltd
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Lupin Pharmaceuticals
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Merck & Co.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Novartis
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Pfizer
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Sanofi
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
10.13. Sun Pharmaceutical Industries Ltd.
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Development
10.14. Viatris
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Development
10.15. Zydus Group
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings